Clinical Trial Update: Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a switch to a darunavir/ritonavir plus maraviroc regimen in R5-tropic HIV with viral DNA genotyping; the GUSTA study has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Maraviroc (maraviroc)
• darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: HIV Infection | Phase 4 | Status: TERMINATED